Aug 20, 2026 07:06AM
Aug 20, 2026 06:57AM
Aug 17, 2026 08:04AM
Aug 6, 2026 07:43AM
Aug 5, 2026 08:41AM
Jul 16, 2026 06:54AM
Jul 16, 2026 06:49AM H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
Jul 9, 2026 06:49AM
Jul 8, 2026 08:02AM
Jun 3, 2026 06:53AM
Jun 2, 2026 01:10PM
Jun 2, 2026 08:00AM
May 19, 2026 06:04AM
May 18, 2026 07:04AM H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
May 13, 2026 08:02AM
May 11, 2026 07:12AM
May 11, 2026 06:36AM
May 6, 2026 08:04AM
Apr 9, 2026 04:18PM
Mar 30, 2026 08:05AM
Mar 3, 2026 07:31AM UroGen Pharma (URGN) PT Raised to $34 at Oppenheimer
Mar 2, 2026 11:20AM
Mar 2, 2026 08:40AM
Mar 2, 2026 08:04AM
Mar 2, 2026 07:55AM
Dec 22, 2025 07:06AM
Nov 6, 2025 09:17AM
Nov 6, 2025 08:21AM UroGen Pharma (URGN) Misses Q3 EPS by 1c
Oct 24, 2025 08:29AM
Oct 2, 2025 08:02AM
Aug 19, 2025 06:18AM
Aug 14, 2025 11:01AM
Aug 11, 2025 06:39AM
Aug 8, 2025 08:33AM
Aug 7, 2025 08:16AM UroGen Pharma (URGN) Misses Q2 EPS by 22c
Jul 21, 2025 08:05AM
Jul 9, 2025 09:41AM
Jul 8, 2025 06:50AM
Jul 7, 2025 08:04AM
Jun 16, 2025 06:34AM
Jun 15, 2025 10:41PM
Jun 15, 2025 06:07AM URGN SHAREHOLDER NOTICE: BFA Law Alerts UroGen Pharma Ltd. Investors to Contact the Firm before Expiration of July 28 Class Action Deadline
Jun 13, 2025 03:16PM
Jun 13, 2025 03:10PM
Jun 13, 2025 10:30AM
Jun 13, 2025 07:46AM
Jun 13, 2025 07:17AM
Jun 13, 2025 07:16AM
Jun 12, 2025 04:00PM URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 12, 2025 01:28PM

443,723 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All